HP
LH icon

HealthInvest Partners’s Labcorp LH Stock Holding History

HealthInvest Partners’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$2.84M Sell
20,719
-28,518
-58% -$3.77M 5.99% 3
2017
Q3 		$6.39M Sell
49,237
-4,074
-8% -$543K 7.46% 10
2017
Q2 		$7.06M Buy
+53,311
New +$6.53M 8.8% 5

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HealthInvest Partners's LH Position: Q4 2017 in Review

HealthInvest Partners reduced its Labcorp (LH) stake by 58% in Q4 2017, selling an estimated $3.77M and leaving 20,719 shares worth $2.84M. The position accounts for 5.99% of the portfolio, ranked #3.

HealthInvest Partners first reported a position in LH in Q2 2017 and has held it in 3 quarters since. The position peaked at $7.06M in Q2 2017. 753 funds tracked by Wall St. Rank hold LH as of Q4 2017.

  • HealthInvest Partners held 20,719 shares of Labcorp worth $2.84M as of Q4 2017.
  • HealthInvest Partners sold 28,518 Labcorp shares in Q4 2017, an estimated $3.77M.
  • Labcorp made up 5.99% of HealthInvest Partners's portfolio in Q4 2017, its #3 holding.
  • HealthInvest Partners first reported a position in Labcorp in Q2 2017 and has held it in 3 quarters since.
  • HealthInvest Partners's Labcorp position peaked at $7.06M in Q2 2017.
  • 753 funds tracked by Wall St. Rank held Labcorp as of Q4 2017.

Based on HealthInvest Partners's 13F filing for Q4 2017, filed 9 Feb 2018.